New centre of excellence aims to drive digital innovation in medicines regulation
Posted:
A new £1 million research initiative aims to transform medicines regulation by accelerating the adoption of digital technologies, including artificial intelligence (AI), in drug development and manufacturing.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us